Category Archives: Medicine Wellness Health

Medicine Wellness Health

www.biolitec.com: New website presents modern medical laser therapies

biolitec® has launched a new website – Functional modern design – Worldwide leading developer and manufacturer of minimally invasive laser therapies – Successful research and development in areas such as phlebology and proctology – 10 years ELVeS®

www.biolitec.com: New website presents modern medical laser therapies

biolitec®_Homepage_en (Source: @biolitec biomedical technology gmbh)

Jena, May 22, 2018 – The developer and manufacturer of medical laser systems for minimally-invasive therapies, biolitec biomedical technology GmbH, has unveiled its new online presence. A modern layout now stands for an adapted innovative website functionality and a better overview of the company’s versatile product and application areas: Thanks to the new tile design, the entire website is structured in a way that the extensive range of medical applications and laser systems of biolitec® can be recognized at first glance.

This principle of fast recognition can be found both in the subject area for doctors and for patients. This, for instance, gives doctors an immediate overview of all biolitec® lasers. For example, if the visitor clicks on the „Dual 100“ tile, he can, due to the simple depiction, see all the therapeutic areas in which this laser can be used.

The same applies to patients: The respective therapy subpages under the menu item „patients“ lead directly to the patient websites adapted to the special needs of patients, such as www.info-varicose-vein.com, which can also be accessed as independent websites.

Founded more than 30 years ago, biolitec® has become one of the world’s leading companies in the field of minimally invasive laser therapies – due to continuous research and development of its products. Thanks to subsidiaries, including in South America and Asia, its innovative laser systems and methods are available for a wide range of applications for gentle and low-intensity treatment options all around the globe. biolitec® lasers are often innovative alternatives to conventional treatment methods in phlebology, proctology, thoracic surgery, urology, gynecology, ENT and orthopedics.

For 10 years now, the unique ELVeS® Radial® 2-ring laser fiber of biolitec®, with its efficient and simple technology, has been convincing in the treatment of varicose veins.

As a result of intensive research, biolitec® has always been able to offer the most modern possibilities in minimally invasive laser medicine. The new LEONARDO® laser family by biolitec® includes the only laser systems available on the market in which two wavelengths can be adjusted and used independently and continuously during the treatment. The universal applicability of the lasers in various fields of application is unique.

Further information on all products and applications of the laser therapies by biolitec® is available directly on the new website www.biolitec.com.

About biolitec
biolitec® is one of the world“s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world“s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®“s field of business. More information available at www.biolitec.com

Contact
biolitec biomedical technology GmbH
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Medicine Wellness Health

First patient treated in First-in-Man study of CoreMedic“s ChordArt™ mitral valve repair system

16 May 2018. Privately-held CoreMedic announces the start of a first-in-man „Chagall“ study to evaluate new minimally-invasive valve repair technology.

CoreMedic is developing ChordArt, a novel transfemoral chordal repair system to address unmet needs in the treatment of degenerative heart disease with mitral valve insufficiency, the most common valve pathology affecting more than 7 million patients worldwide. The ChordArt implant is used to replace the ruptured or elongated chordae of the valve and re-establishes the connection of the valve leaflets with the papillary muscle to restore the proper function. As ChordArt reduces the complexity of the procedure, both patients and physicians will benefit.

The „Chagall“ Trial is a prospective, multicenter, first-in-man study intended to establish the safety and effectiveness of the ChordArt System. The study was approved to enroll up to 40 subjects at up to 6 European centers. This study is the first trial of its kind to treat patients that have ruptured or elongated mi-tral chords with the ChordArt System.

The first-in-man (FIM) case using ChordArt was treated by the Heart Team led by Prof. Kstutis Ručinskas at the Vilnius Uni-versity Hospital, Lithuania. The ChordArt treatment was aimed at improving procedural outcomes and allowing standardized placement of the artificial chords with a dedicated, reproducible technique.

The patient recovered very well from the intervention and is continuously doing well. A 30 day follow-up showed no complications.

„Using the ChordArt reduced the invasiveness and duration of the procedure by repairing the valve in a fast, precise and safe way. This allowed the Heart Team to focus on the procedure and timing rather than manually placing the artificial chords to resolve the mitral insufficiency“ said Dr. Alberto Weber, Her-zzentrum Hirslanden, Zurich, Switzerland, who proctored the procedure. „Thanks to the ease of the ChordArt deployment technique, this was the fastest mitral valve chordal repair I have ever witnessed.“

For Thomas Bauer, CEO of CoreMedic, „The first clinical use of ChordArt is a major milestone in our path towards developing the best in class transfemoral mitral valve chordal repair system“. Hubertus Leonhardt, Managing Partner of medical device investor SHS, commented: „In 2017 we invested in CoreMedic to advance the development of ChordArt. We look forward to the results of clinical trials that will validate the applications of this breakthrough device.“

About Mitral Regurgitation:
Mitral valve regurgitation (MR) is a condition in which the mitral valve leaflets fail to close properly, allowing significant backflow of blood from the left ventricle into the left atrium during systole. Valve disease prevalence rises dramatically with age, reaching epidemic levels in the elderly.
MR is the most common valve pathology in the US. Over 7 million people suffer from the disease and each year 250,000 patients are diagnosed with MR. If untreated, MR can cause shortness of breath, decreased cardiac output, intolerance to physical exercise, congestive heart failure and death.
The standard-of-care in surgically treating degenerative MR involves replacing ruptured or elongated valve chordae with artificial implants to restore the function of the valve.
Implanting the standard artificial chordae requires complex and long procedural steps. This complexity is associated with risks including failure of the valve repair or the need to repeat the operation, the use of a cardiac bypass machine and stopping the heart.

About CoreMedic:
CoreMedic is dedicated to develop devices and therapies to dramatically improve the quality of life of patients with heart valve diseases, a primary challenge in global healthcare.
CoreMedic“s flagship product ChordArt is a transfemoral system for mitral valve chordal repair in the beating heart. ChordArt™ offers a first line therapy option for patients with mitral valve dysfunction and represents a less invasive procedure compared to the current surgical methods with open-chest or trans-apical access. ChordArt is designed to allow mitral repair in a wider patient population. ChordArt™ is currently under clinical evaluation in European clinics.
CoreMedic is a privately held medical device company headquartered in Radolfzell, Germany with a subsidiary in Biel/Bienne, Switzerland. CoreMedic is EN ISO 13485 certified.
The investor base consists of founders, private investors and medical device investor SHS Gesellschaft für Beteiligungsmanagement mbH ( www.shs-capital.eu).
For further information, please visit www.coremedic.ch

Company-Contact
CoreMedic GmbH
Thomas Bauer
Bismarckstrasse 12
72072 Tübingen
Phone: 089 20003038
E-Mail: info@coremedic.ch
Url: http://www.coremedic.ch

Press
IWK GmbH
Dr. Reinhard Saller
Ohmstr. 1
80802 München
Phone: 089 20003038
E-Mail: reinhard.saller@iwk-cp.com
Url: http://www.iwk-cp.com

Medicine Wellness Health

Alzheimer’s disease: Patients benefit from nuclear imaging

(Vienna, 19 April 2018) With the help of Positron emission tomography (PET) Alzheimer“s disease (AD) can be detected long before the onset of the symptoms by making beta-amyloid in the brain visible. However, since there is still no cure for AD the question has been raised if such a diagnosis is really beneficial for the patient or rather more of a burden. First results of a large study, currently under way, show that PET diagnosis helped to improve medical management and counseling in over 65% of the patients. „AD patients clearly benefit from nuclear imaging,“ says Dr. Valentina Garibotto, expert of the European Association of Nuclear Medicine (EANM).

Alzheimer“s disease is the most frequent cause of dementia and one of the most important causes of disability in the elderly. The condition induces a decline in mental ability that usually develops and progresses slowly. Memory and judgment are impaired, and personality may deteriorate. The target of the PET examination is beta-amyloid, which is the chief component of plaques that are one of the hallmarks of Alzheimer“s. Recently developed tracers (radioactively labelled substances the patient is injected with) make these plaques visible on the computer screen. By applying this method the likelihood of Alzheimer“s disease can be established in patients with a higher degree of certainty, as compared with other routine diagnostic tools.

PET exams improve health care management
While its accuracy is uncontroversial the benefit of nuclear imaging for AD patients has frequently been questioned: Since there is no cure for this disease the gained diagnostic knowledge might be considered not only useless but an unnecessary psychological burden for the patient while he is still fit. In order to clarify this matter and to examine the actual impact of PET procedures on AD patient care and health outcome two large studies are currently under way: The IDEAS study (Imaging Dementia-Evidence for Amyloid Scanning) in the USA (www.ideas-study.org) and the AMYPAD study (Amyloid Imaging to prevent AD) in Europe (amypad.eu).

IDEAS started in 2016 and includes 18.000 participants. First results show that the outcome of PET scans have concrete beneficial consequences: They led to a change in medical and general health care management in around 65% of the patients. These changes consisted among other things in different drug prescriptions, making use of the fact that amyloid imaging allows doctors to determine with high accuracy whether in patients with mild symptoms Alzheimer“s is the cause or whether it can be excluded, so that some other kind of dementia or another condition has to be taken into account. Thus, depending on the PET exam results doctors changed to drugs specific for Alzheimer (namely aceltycholinesterase inhibitors) or they reversely abandoned these drugs in favor of a better suited medication, for exampleantidepressants or antipsychotics. PET scan results in favor of AD also induced an appropriate counseling about safety and future planning, thus helping patients and their friends and family to avoid preventable risks. For example, a diabetic who is also diagnosed with AD would not be left alone any longer to manage his insuline doses. „These interim results already provide convincing evidence that AD patients benefit largely from a more accurate diagnosis and we expect further study outcomes to complete the picture,“ says Dr. Valentina Garibotto of the EANM Neuroimaging Committee.

Nuclear imaging pivotal in AD research
Further important insights are to be expected of the AMYPAD study which has just started. This is a collaborative research initiative and part of the European Innovative Medicines Initiative (IMI). The overall goal of the program is to determine the value of amyloid PET imaging to diagnose and guide treatment, namely clinical trials, in AD. „Despite the hitherto unsatisfying results of therapeutic trials, our knowledge and understanding of AD has dramatically evolved over the last decades and PET imaging has played and still plays an increasingly central role. Accordingly, the next EANM focus meeting will be fully dedicated to the field of neuroimaging in AD. Entitled „Molecular Imaging of Dementia – The future is here“ it will invite worldwide experts to update the community on the latest developments,“says Dr. Garibotto.

www.whatisnuclearmedicine.com
www.eanm.org

Presseagentur für Medizinthemen

Contact
impressum health & science communication
Frank von Spee
Hohe Brücke 1
20459 Hamburg
Phone: 040 31786410
E-Mail: vonspee@impressum.de
Url: http://www.impressum.de

Medicine Wellness Health

LEONARDO® DUAL by biolitec®: First medical laser for multifunctional applications in minimally invasive therapies

LEONARDO® laser family first universally applicable medical laser system with a combination of two wavelengths for use in several disciplines

LEONARDO® DUAL by biolitec®: First medical laser for multifunctional applications in minimally invasive therapies

biolitec® LEONARDO® DUAL lasers family (Source: biolitec biomedical technology GmbH)

Jena, April 19th, 2018 – The unique medical laser system LEONARDO® DUAL consists of lasers with 45 watt, 100 watt and 200 watt power ranges. These lasers are the most versatile medical lasers available for medical la-ser treatments, offering a variety of tissue interactions – for open and for endoscopic procedures with contact or non-contact delivery options. The possibility to use two wavelengths in one compact, mobile and space-saving laser system constitutes a clear benefit for the user, just as the multidisciplinary use of the lasers and the low-maintenance. Each wavelength can be individually selected or blended together to offer the desired tissue effects, such as incision, excision, vaporization, hemostasis and coagulation of soft tissue. All of the lasers are equipped with the two wavelengths of 980 nm and 1470 nm, which can be continuously used during the treatment.

The new LEONARDO® DUAL series lasers are suitable for minimally invasive procedures in phlebology, proctology, urology, gynecology, orthopedics, thoracic surgery, pneumology, ENT and aesthetic surgery. As the lasers feature not only a wavelength of 980 nm but also of 1470 nm, they are also ideally suited for the use in phlebology. The laser procedure with a wavelength of 1470 nm minimizes any post-operative inflammatory pain and bruising, due to a 400 times greater absorption coefficient in water compared to 810 nm lasers targeting hemoglobin. In addition, an easy-to-use system for a significantly improved treatment outcome is provided by means of the radial (360°) emission of the patented ELVeS® Radial® 2ring fiber.

The ELVeS® Radial® 2ring fiber splits the energy in two phases, which leads to an effective closure of the vein. By avoiding perforation of the vein wall and associated thermal irritation of the surrounding tissue, post-operative pain is minimized. The ELVeS® Radial® 2ring slim fiber was especially designed for the treatment of superficial venous reflux on perforator veins and small saphenous veins.

With the biolitec® therapies FiLaC® (Fistula-tract Laser Closure for anal fistulae), SiLaC (Sinus Pilonidalis treatment) and LHP® (LaserHemorrhoidoPlasty for hemorrhoids) for proctology, biolitec® introduced a new innovative minimally invasive method, where the diseased tissue is irradiated from the inside with the laser energy and thus gently destroyed.

Also part of the family and suitable for varicose vein treatment is the LEONARDO® Mini 1470 nm. Weighing only 900 grams, this device can be used mobile in the established treatment methods of biolitec® for venous diseases and other medical treatments. Besides the lasers, biolitec® provides a wide range of accessories and offers suitable fibers with specific characteristics that are perfectly coordinated with versatile therapeutic areas and the respective application, due to continuous research and development.

If you are interested in presentations or congresses on the subject of minimally invasive medical laser therapies by biolitec®, please have a look at our website www.biolitec.com (section Company/Events).

About biolitec
biolitec® is one of the world“s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world“s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®“s field of business. More information available at www.biolitec.com

Contact
biolitec biomedical technology GmbH
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Medicine Wellness Health

Global Dosing Systems Market Status and Prospect, Forecast 2018 to 2026

Global Dosing Systems Market Status and Prospect, Forecast 2018 to 2026

Dosing systems are commonly used to inject fluids or chemicals in large or small quantity in production & processing, and is used in various processing and manufacturing industries such as textile, thermal power stations, oil & gas, water treatment, food & beverages, pharmaceuticals, paper & pulp, chemical processes, etc. Dosing systems are designed with high accuracy, and it ensures high safety, and security measures, longer service life, and excellent performance.

Increasing importance of wastewater treatment by national governments, and increase in production rate of pharmaceuticals and chemical processing industries are key factors driving growth of the global dosing systems market over the forecast period. In addition, increasing preference for dosing systems, owing to factors such as faster outputs, impart precision, and effectiveness are expected to fuels growth of the global dosing systems market. Moreover, increasing consumer awareness, and technological advancement with chemical processing industries are expected to further fuel growth of the global dosing systems market over the forecast period.

However, high cost of raw materials, and increasing number of coal bed methane reserves are key factors restraining growth of the global dosing systems market over the forecast period. In addition, issues related to lack of greenfield investments is another factor expected to hamper growth of the global dosing systems market in the near future.

Moreover, increasing trend towards automation, innovation, and increasing number of software in these systems are expected to spur demand for dosing systems during the forecast period.

Do Inquiry of the Report Here: https://marketresearch.biz/report/dosing-systems-market/#inquiry

The market in North America dominates the global dosing systems market in terms of revenue, owing to rapidly growing industrial sectors, followed by Europe respectively. The market in Asia Pacific is expected to witness highest growth in terms of revenue during the forecast period owing to presence of manufacturing facilities of large chemical, food & beverages, paper & pulp, and pharmaceutical companies in countries in this region.

Key players in the global dosing systems market include GRUNDFOS GMBH, IDEX Corporation, ProMinent GmbH, Seko S.p.A., EMEC S.r.l., Gee & Company (Effluent Control & Recovery) Limited, LEWA GmbH, and NETZSCH Pumpen & Systeme GmbH, Blue-White Industries, Ltd., and SPX Corporation.

Prudour Pvt. Ltd. ( https://marketresearch.biz) is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. Prudour Pvt. Ltd. offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact
MarketResearch.Biz
Krutika Bhoot
Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300 NY
10170 New York City
Phone: +1 347 826 1876
E-Mail: krutika@marketresearch.biz
Url: https://marketresearch.biz/

Medicine Wellness Health

Global Infection Control Market Status and Prospect, Forecast 2018 to 2026

Global Infection Control Market Status and Prospect, Forecast 2018 to 2026

Infection control is concerned with preventing health care associated infection and aseptic technique is a major component of all invasive surgical process. Infection prevention and control plays crucial role in hospital and clinics, as it prevents the spread of infections in healthcare settings. According to World Health Organization data, 1 in 10 patients get an infection while receiving care. Furthermore, preventing infection control can reduce 30% of health care-associated infections. Hospital acquired infection is most common in intensive care unit and are significantly associated with increased morbidity and mortality. Moreover, infection control affects patient recovery.

Increasing incidence of hospital acquired infection is expected to drive the growth of infection control market. Moreover, rising awareness about several infections and increased hospital admission, owing to the rapidly growing geriatric population are other factors anticipated to further drive growth of the global infection control market over the forecast period. In addition, increasing demand for non-disposable surgical equipment in hospitals/clinics and increasing number of surgical procedure is anticipated to future drive the growth of the global infection control market over the forecast period.

Technological advancement and drug innovation resulting in minimal hospital stay is major factor restraining growth of the global infection control market.

The global infection control market report has been segmented on the basis of type, application, and region. On the basis of region, the global infection control market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Do Inquiry of the Report Here: https://marketresearch.biz/report/infection-control-market/#inquiry

North America market dominates the global infection control market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel, rising regulatory concerns and government initiatives in the region. Europe accounts for second-largest revenue share contribution to the global infection control market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the growing demand for infection control products and services and increasing number of surgical procedures in the region.

Some prominent players in the global infection control market are 3M Company, MMM Group, Metrex Research, LLC., Cantel Medical Corporation, Belimed AG, STERUS Corporation, Getinge Group, Halyard Health, and Pal International

Prudour Pvt. Ltd. ( https://marketresearch.biz) is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. Prudour Pvt. Ltd. offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact
MarketResearch.Biz
Krutika Bhoot
Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300 NY
10170 New York City
Phone: +1 347 826 1876
E-Mail: krutika@marketresearch.biz
Url: https://marketresearch.biz/

Medicine Wellness Health

Global Melanoma Therapeutics Market Status and Prospect, Forecast 2018 to 2026

Global Melanoma Therapeutics Market Status and Prospect, Forecast 2018 to 2026

Melanoma is a form of skin cancer that arises when pigment-producing cells mutates and become cancerous. Pigmented cells are found in skin and occur in other part of body such as intestine, and eyes. Melanoma is one of type of skin cancer which is less common than basal cell and squamous cell skin cancer. However, melanoma is considered as dangerous type of skin cancer as these cancerous growths develop when unrepaired DNA damage to skin cells and they are likely to spread in the body. Melanoma is caused due to exposure to ultraviolet radiation form the sun and from tanning lamp.

Increasing prevalence of melanoma, skin allergies and skin cancer is expected to drive the growth of melanoma therapeutics market. Moreover, rising awareness about the melanoma globally, coupled with several government and non-profit organizations providing education and support services is anticipated to further drive growth of the global melanoma therapeutics market over the forecast period. Furthermore, increasing number of approvals for novel therapeutics is expected to boost the growth of melanoma therapeutics market over the forecast period.

A major factor restraining growth of the global melanoma therapeutics market is high cost for treatment.
However, technological advancements and innovations focusing on development of biologics for treatments is expected to create new opportunities for major players in the global melanoma therapeutics market over the forecast period.

The global melanoma therapeutics market report has been segmented on the basis of therapy type, stage, and region. On the basis of region, the global melanoma therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Do Inquiry of the Report Here: https://marketresearch.biz/report/melanoma-therapeutics-market/#inquiry

North America market dominates the global melanoma therapeutics market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and increasing number of skin cancer cases in the region. Europe accounts for second-largest revenue share contribution to the global melanoma therapeutics market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing investment by key market players in emerging market and increasing demand for cost-efficient therapeutics.

Some prominent players in the global sterilization equipment market are Amgen, Inc., F. Hoffman-La Roche Ltd., Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc., AstraZeneca, AB Sciences, Celgene Corporation, Galectin Therapeutics, and Ziopharm Oncology, Inc.

Prudour Pvt. Ltd. ( https://marketresearch.biz) is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. Prudour Pvt. Ltd. offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact
MarketResearch.Biz
Krutika Bhoot
Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300 NY
10170 New York City
Phone: +1 347 826 1876
E-Mail: krutika@marketresearch.biz
Url: https://marketresearch.biz/

Medicine Wellness Health

Global Needles Market Status and Prospect, Forecast 2018 to 2026

Global Needles Market Status and Prospect, Forecast 2018 to 2026

Needles are thin, cylindrical or hollow objects, with a sharp tip, and are basically used to inject drugs (medication) into the muscle or under the skin. Surgical needles are used for suturing, biopsies, delivery of Radio Frequency Identification (RFID) microchips, delivery of electrical impulses, holding thermocouples for temperature measurement, guiding other devices such as guidewires and catheters, and numerous other applications.

Rising prevalence of diseases across the globe and more rapid effect and efficiency of drugs and medication through direct delivery into the systemic circulation are two major factors contributing to growth of the global needles market. Other factors include increasing global geriatric population and increasing number of hospitals in emerging economies. In addition, high prevalence of chronic and lifestyle-associated diseases, increasing demand for vaccines, rising prevalence of diabetes, increasing incidence of cancer and spine disorders, and growing need for blood for transfusions are other factors driving growth of the global needle market.
Incorrect administrating of injections and use of surgical needles can cause infection and bleeding, and this coupled with easy availability of alternative drug delivery methods and needle anxiety among other are some factors expected to hamper growth of the global needles market to a certain extent over the forecast period.

Currently, the market in North America dominates the global needles market in terms of revenue. The market in Asia Pacific represents high-growth opportunities for major players in the market owing to increasing adoption of needles, which is expected to boost growth of the global needles market over the forecast period.

Do Inquiry of the Report Here: https://marketresearch.biz/report/needles-market/#inquiry

The global needles market report has been segmented on the basis of type, product, delivery mode, end user and region.
Currently, the market in North America dominates the global needles market in terms of revenue. The market in emerging Asian countries offer high-growth opportunities for market players, owing to increasing adoption for needles expected to boost growth of the global needles market.

Key players in the global needles market include Medtronic plc,Ethicon US, Misawa Medical Industry Co. Ltd., Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Terumo Corporation, B. Braun Melsungen AG, Unilife Corp., Boston Scientific Corporation, Novo Nordic A/S Medtronic plc, Ethicon US, Misawa Medical Industry Co. Ltd., Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Terumo Corporation, B Braun, Unilife Corp., Boston Scientific Corporation, and Novo Nordic.

Prudour Pvt. Ltd. ( https://marketresearch.biz) is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. Prudour Pvt. Ltd. offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact
MarketResearch.Biz
Krutika Bhoot
Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300 NY
10170 New York City
Phone: +1 347 826 1876
E-Mail: krutika@marketresearch.biz
Url: https://marketresearch.biz/

Medicine Wellness Health

Global Cancer/Tumor Profiling Market Status and Prospect, Forecast 2018 to 2026

Global Cancer/Tumor Profiling Market Status and Prospect, Forecast 2018 to 2026

Cancer/tumor profiling technique provides genetic information in cancer cell. It also classifies tumors more accurately and helps oncologist to select appropriate therapy for the treatment of cancer. In case of breast cancer, tumor profiling may predict whether the cancer is more likely to recur. The immunohistochemistry (IHC) is a technology used to determine the level of protein expression in a tumor whereas, next-generation sequencing is used to examine and detect mutations in DNA sequences. Thus, the cancer/tumor profiling can avoid the over treatment of cancer patients.

Increasing number of cancer cases globally and increasing funding by several organizations for cancer research are major factors contributing to growth of the global cancer/tumor profiling market. In addition, rise in adoption of the cancer profiling methods by oncologist are other factors contributing to growth of the global cancer/tumor profiling market. Moreover, rising awareness about cancer globally, coupled with several governments and non-profit organizations providing education and support services, is anticipated to further drive growth of the global cancer/tumor profiling market over the forecast period.

A major factor restraining growth of the global cancer/tumor profiling market is high cost for development of biomarkers.
The global cancer/tumor profiling market report has been segmented on the basis of technologies, technique, application, and region. On the basis of region, the global cancer/tumor profiling market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Do Inquiry of the Report Here: https://marketresearch.biz/report/cancer-tumor-profiling-market/#inquiry

North America market dominates the global cancer/tumor profiling market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and increasing number of cancer cases in the region. Europe accounts for second-largest revenue share contribution to the global cancer/tumor profiling market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing investment by key market players in emerging market and increasing demand for advanced healthcare services.

Some prominent players in the global sterilization equipment market are Illumina, Inc., Qiagen N.V., Neogenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc., Caris Life Sciences, Helomics Corporation, Nanostring Technologies, Inc., Ribomed Biotechnologies, Inc., and Oxford Gene Technology

Prudour Pvt. Ltd. ( https://marketresearch.biz) is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. Prudour Pvt. Ltd. offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact
MarketResearch.Biz
Krutika Bhoot
Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300 NY
10170 New York City
Phone: +1 347 826 1876
E-Mail: krutika@marketresearch.biz
Url: https://marketresearch.biz/

Medicine Wellness Health

Global Sterilization Equipment Market Status and Prospect, Forecast 2018 to 2026

Global Sterilization Equipment Market Status and Prospect, Forecast 2018 to 2026

Sterilization is a technique which eliminates, removes, kills, or deactivates all form of life providing an aseptic environment. Sterilization equipment is used to prevent contamination and also to minimize risk of infection. Sterilization can be achieved through various means such as chemicals, heat, radiation, filtration, and high pressure. Sterilization is done for reagents, media, and instrument which are used during the process. The steam or autoclave sterilization is most commonly used for instrument sterilization.

Sterilization equipment market is expected to gain traction due to increasing investment by market players in research and development activities. Furthermore, rising incidence of hospital acquired infections and increasing awareness about health and hygiene among individuals is expected to drive growth of the global sterilization equipment market. In addition, increasing demand for non-disposable surgical equipment in hospitals and increasing number of surgical procedure is anticipated to future drive the growth of the global sterilization equipment market over the forecast period.

A major factor restraining growth of the global sterilization equipment market is high cost and regulatory compliance issues of sterilization equipment.

The global sterilization equipment market report has been segmented on the basis of technique, end-user, and region. On the basis of region, the global sterilization equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Do Inquiry of the Report Here: https://marketresearch.biz/report/sterilization-equipment-market/#inquiry

North America dominates the global sterilization equipment market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure, availability of skilled medical personnel, and increasing number of surgical procedures in the region. The market in Europe accounts for second-largest revenue share contribution to the global sterilization equipment market, followed by the markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the growing number of pharmaceutical companies and research centers.

Some prominent players in the global sterilization equipment market are STERIS Corporation, Getinge Group, Advanced Sterilization Products, 3M Company, Belimed AG, Cantel Medical Corporation, Anderson Products, Inc., Matachana Group, Sterigenics International, Inc., and TSO3.

Prudour Pvt. Ltd. ( https://marketresearch.biz) is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. Prudour Pvt. Ltd. offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact
MarketResearch.Biz
Krutika Bhoot
Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300 NY
10170 New York City
Phone: +1 347 826 1876
E-Mail: krutika@marketresearch.biz
Url: https://marketresearch.biz/